FBLG logo

FIBROBIOLOGICS INC

FBLGNASDAQ
πŸ† #4904 by market capEarnings Feb 23US Equity
$0.71β–Ό $0.12 (βˆ’15.06%)
Market closed Β· at close
πŸ””
Track FBLG
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 15.1%
7dβ–Ό 27.1%
14dβ–Ό 22.8%
30dβ–Ό 31.6%
ytdβ–Ό 84.1%
1yβ–Ό 89.5%
🏦Market Cap
$5M
Small Cap
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
β€”
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$0.70 – $0.87
52-Week Range
$0.62 – $9.60
Volume (shares)
49,626
Avg Volume (shares)
β€”
Shares Outstanding
7.0M
Next Earnings
2027-02-23

Fundamentals Snapshot

Annual Revenue
β€”
Last Q Revenue
β€”
P/E Ratio
β€”
P/S Ratio
β€”
EPS (TTM)
$-5.74
Dividend Yield
β€”
Dilution (1yr)
+91.3%
FBLG logo

FIBROBIOLOGICS INC

FBLG
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$17Mβ–² +21.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$17Mβ–² +37.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
3.3Mβ–² +91.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$2Mβ–Ό βˆ’$948K YoY
StockOtter Β· stockotter.space

About FIBROBIOLOGICS INC

FibroBiologics, Inc. operates as a clinical-stage biopharmaceutical firm, advancing therapies derived from fibroblasts toward commercialization within the United States. The company's pipeline includes CybroCell, currently being developed to address degenerative disc disease; CYMS101, targeting multiple sclerosis; and CYWC628 for wound repair. Further demonstrating its broad scope, early-stage investigations are underway for CYTER915, aimed at restoring or enhancing thymus and/or spleen function; CYPS317, for psoriasis; and TCB190, designed to combat specific cancers. FibroBiologics was founded in 2021 and is situated in Houston, Texas.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.